FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001464002> ?p ?o ?g. }

• W2001464002 endingPage "44" @default.
• W2001464002 startingPage "35" @default.
• W2001464002 abstract "There are limited data examining the real-world use of gabapentin and pregabalin for the treatment of post-herpetic neuralgia (PHN). This study examines dosing patterns, therapy outcomes, healthcare utilization and costs of patients with PHN who initiate treatment with gabapentin or pregabalin. This was a retrospective administrative claims data analysis from July 2005 to February 2010. Patients with PHN initiating gabapentin or pregabalin (index therapy) from January 2006 to February 2009 were identified and were observed for 12 months after index therapy initiation. Outcomes were mean daily dosages of the index therapy, attainment of minimally effective dosages of gabapentin (≥1,800 mg/day) or pregabalin (≥150 and ≥300 mg/day) persistence, discontinuation, index therapy switching, addition of neuropathic pain medications to index therapy, and healthcare resource use and costs. 1,645 patients were identified. The mean daily dosage was 826 mg for gabapentin and 187 mg for pregabalin. Only 52.6 % of patients initiating gabapentin and 56.9 % initiating pregabalin obtained a refill during the post-index period. Approximately 14 % of patients treated with gabapentin reached the target dosage (1,800 mg/day). For pregabalin, 87 % reached ≥150 mg/day and 27 % reached ≥300 mg/day. On average, patients took 10 weeks to reach 1,800 mg/day gabapentin, and 5.0 and 9.2 weeks to reach ≥150 mg/day and ≥300 mg/day pregabalin, respectively. Approximately one-third of patients in both index therapy cohorts added a pain medication; more than half added opioids. The percentage of patients switching from either drug (57 %) or adding a therapy (34 %) were similar between index therapy cohorts; opioids were the most common therapy patients switched to or added. It appears that gabapentin and pregabalin are not used effectively to treat PHN. Suboptimal dosing and discontinuation may be associated with supplementary use of other analgesics, especially opioids." @default.
• W2001464002 created "2016-06-24" @default.
• W2001464002 creator A5024372785 @default.
• W2001464002 creator A5026232658 @default.
• W2001464002 creator A5073041900 @default.
• W2001464002 creator A5081079219 @default.
• W2001464002 date "2012-11-23" @default.
• W2001464002 modified "2023-10-16" @default.
• W2001464002 title "Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin" @default.
• W2001464002 cites W1826161993 @default.
• W2001464002 cites W1968122055 @default.
• W2001464002 cites W1971312160 @default.
• W2001464002 cites W1980564212 @default.
• W2001464002 cites W1991565511 @default.
• W2001464002 cites W1994111485 @default.
• W2001464002 cites W2014670473 @default.
• W2001464002 cites W2016474170 @default.
• W2001464002 cites W2023954230 @default.
• W2001464002 cites W2039982019 @default.
• W2001464002 cites W2042071004 @default.
• W2001464002 cites W2057983296 @default.
• W2001464002 cites W2060579001 @default.
• W2001464002 cites W2061326496 @default.
• W2001464002 cites W2071419929 @default.
• W2001464002 cites W2084567915 @default.
• W2001464002 cites W2091329435 @default.
• W2001464002 cites W2122540356 @default.
• W2001464002 cites W2136743000 @default.
• W2001464002 cites W2147962719 @default.
• W2001464002 cites W2149130129 @default.
• W2001464002 cites W2154692607 @default.
• W2001464002 cites W2159977024 @default.
• W2001464002 cites W2328445755 @default.
• W2001464002 cites W2329242769 @default.
• W2001464002 cites W2906486020 @default.
• W2001464002 doi "https://doi.org/10.1007/s40261-012-0030-4" @default.
• W2001464002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3586179" @default.
• W2001464002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23179473" @default.
• W2001464002 hasPublicationYear "2012" @default.
• W2001464002 type Work @default.
• W2001464002 sameAs 2001464002 @default.
• W2001464002 citedByCount "26" @default.
• W2001464002 countsByYear W20014640022013 @default.
• W2001464002 countsByYear W20014640022014 @default.
• W2001464002 countsByYear W20014640022015 @default.
• W2001464002 countsByYear W20014640022016 @default.
• W2001464002 countsByYear W20014640022017 @default.
• W2001464002 countsByYear W20014640022018 @default.
• W2001464002 countsByYear W20014640022019 @default.
• W2001464002 countsByYear W20014640022020 @default.
• W2001464002 countsByYear W20014640022021 @default.
• W2001464002 countsByYear W20014640022022 @default.
• W2001464002 countsByYear W20014640022023 @default.
• W2001464002 crossrefType "journal-article" @default.
• W2001464002 hasAuthorship W2001464002A5024372785 @default.
• W2001464002 hasAuthorship W2001464002A5026232658 @default.
• W2001464002 hasAuthorship W2001464002A5073041900 @default.
• W2001464002 hasAuthorship W2001464002A5081079219 @default.
• W2001464002 hasBestOaLocation W20014640021 @default.
• W2001464002 hasConcept C126322002 @default.
• W2001464002 hasConcept C142724271 @default.
• W2001464002 hasConcept C162156334 @default.
• W2001464002 hasConcept C204787440 @default.
• W2001464002 hasConcept C2776468701 @default.
• W2001464002 hasConcept C2776608144 @default.
• W2001464002 hasConcept C2777107010 @default.
• W2001464002 hasConcept C2777288759 @default.
• W2001464002 hasConcept C2778715236 @default.
• W2001464002 hasConcept C2780016216 @default.
• W2001464002 hasConcept C42219234 @default.
• W2001464002 hasConcept C71924100 @default.
• W2001464002 hasConceptScore W2001464002C126322002 @default.
• W2001464002 hasConceptScore W2001464002C142724271 @default.
• W2001464002 hasConceptScore W2001464002C162156334 @default.
• W2001464002 hasConceptScore W2001464002C204787440 @default.
• W2001464002 hasConceptScore W2001464002C2776468701 @default.
• W2001464002 hasConceptScore W2001464002C2776608144 @default.
• W2001464002 hasConceptScore W2001464002C2777107010 @default.
• W2001464002 hasConceptScore W2001464002C2777288759 @default.
• W2001464002 hasConceptScore W2001464002C2778715236 @default.
• W2001464002 hasConceptScore W2001464002C2780016216 @default.
• W2001464002 hasConceptScore W2001464002C42219234 @default.
• W2001464002 hasConceptScore W2001464002C71924100 @default.
• W2001464002 hasIssue "1" @default.
• W2001464002 hasLocation W20014640021 @default.
• W2001464002 hasLocation W20014640022 @default.
• W2001464002 hasLocation W20014640023 @default.
• W2001464002 hasLocation W20014640024 @default.
• W2001464002 hasOpenAccess W2001464002 @default.
• W2001464002 hasPrimaryLocation W20014640021 @default.
• W2001464002 hasRelatedWork W1542616571 @default.
• W2001464002 hasRelatedWork W1741935204 @default.
• W2001464002 hasRelatedWork W2001464002 @default.
• W2001464002 hasRelatedWork W2130359686 @default.
• W2001464002 hasRelatedWork W2160648582 @default.
• W2001464002 hasRelatedWork W2741645187 @default.
• W2001464002 hasRelatedWork W2935114587 @default.
• W2001464002 hasRelatedWork W2973537373 @default.

• next